LTCR-H2-1

N/A

Report date: 2025/01/26 16:04:41

Base Information

Drug NameLTCR-H2-1

Drug Alias Nameautologous HBV specific TCR-redirected T cells (Lion TCR)LTCR-H2-1

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionHistocompatibility antigens class I modulators

TargetsHistocompatibility antigens class I

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLion Tcr Pte Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLion Tcr Pte Ltd

Inactive CompaniesN/A

Active IndicationsHepatitis B

Inactive IndicationsN/A

Other Information

ATC CodeN/A